Company Profile
Wave Life Sciences Stock Price, News & Analysis
- Ticker:
- WVE
- Exchange:
- NASDAQ
- Sector:
- Life Science Tools
- Location:
- United States
Stock performance
5.89 USD (-0.51%)
Close
Last updated: July 28, 2026
1.09B USD
Market cap
Why the stock is moving
As of Jul 28, 2026, WVE closed down 0.51% at $5.89. No new same-company headline was identified in the current news window.
Company overview
Business overview
Wave Life Sciences is an RNA-focused company developing precision medicines for genetic diseases. Its platform aims to improve oligonucleotide performance and target difficult disease biology.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Wave sits in advanced RNA biotechnology.
Business Model Characteristics
The model depends on clinical validation, platform delivery, and the possibility of building a durable genetic-medicine franchise.
Position Within the Biotechnology Landscape
Wave is a platform RNA name whose stock reacts to proof that its chemistry can deliver differentiated biology.
Future catalysts
Wave’s next catalysts are WVE-006 and the rest of its RNA-editing pipeline, especially any human data that show the chemistry can translate beyond theory. The market is still waiting for proof that the platform can produce durable clinical benefit.
Recent news
- 01
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
Source: Wave Life Sciences
- 02
- 03
- 04
Wave Life Sciences to Present at Upcoming Investor Conferences
Source: Wave Life Sciences
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Wave Life Sciences (WVE)?
Wave Life Sciences (WVE) most recently closed at 5.89 USD, a -0.51% move versus the previous session.
What is the market cap of Wave Life Sciences (WVE)?
Wave Life Sciences currently has a market capitalization of 1.09B USD on BioPharmSignal.
What does Wave Life Sciences do?
Wave Life Sciences is an RNA-focused company developing precision medicines for genetic diseases. Its platform aims to improve oligonucleotide performance and target difficult disease biology.
On which exchange is WVE stock listed?
Wave Life Sciences (WVE) is associated with NASDAQ, United States, Life Science Tools.
What is WVE-006?
Wave’s next catalysts are WVE-006 and the rest of its RNA-editing pipeline, especially any human data that show the chemistry can translate beyond theory.
Which conditions is Wave Life Sciences targeting with WVE-006?
Wave Life Sciences is associated with genetic disease based on its company overview and current catalyst commentary.
How does Wave Life Sciences describe recent progress with WVE-006?
Wave’s next catalysts are WVE-006 and the rest of its RNA-editing pipeline, especially any human data that show the chemistry can translate beyond theory.
What is Wave?
Wave Life Sciences is an RNA-focused company developing precision medicines for genetic diseases.